These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 8640234

  • 1. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
    Naski MC, Wang Q, Xu J, Ornitz DM.
    Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I.
    d'Avis PY, Robertson SC, Meyer AN, Bardwell WM, Webster MK, Donoghue DJ.
    Cell Growth Differ; 1998 Jan; 9(1):71-8. PubMed ID: 9438390
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation.
    Yamanaka Y, Tanaka H, Koike M, Nishimura R, Seino Y.
    J Bone Miner Res; 2003 Aug; 18(8):1395-403. PubMed ID: 12929929
    [Abstract] [Full Text] [Related]

  • 9. A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online.
    Grigelioniené G, Hagenäs L, Eklöf O, Neumeyer L, Haereid PE, Anvret M.
    Hum Mutat; 1998 Aug; 11(4):333. PubMed ID: 10215410
    [Abstract] [Full Text] [Related]

  • 10. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.
    Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, Donoghue DJ.
    Oncogene; 2000 Jul 06; 19(29):3309-20. PubMed ID: 10918587
    [Abstract] [Full Text] [Related]

  • 11. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
    Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A.
    Nature; 1994 Sep 15; 371(6494):252-4. PubMed ID: 8078586
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.
    Cormier S, Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L, Bonaventure J, Silve C.
    Am J Pathol; 2002 Oct 15; 161(4):1325-35. PubMed ID: 12368206
    [Abstract] [Full Text] [Related]

  • 13. Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts.
    Nguyen HB, Estacion M, Gargus JJ.
    Hum Mol Genet; 1997 May 15; 6(5):681-8. PubMed ID: 9158142
    [Abstract] [Full Text] [Related]

  • 14. Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.
    Ronchetti D, Greco A, Compasso S, Colombo G, Dell'Era P, Otsuki T, Lombardi L, Neri A.
    Oncogene; 2001 Jun 14; 20(27):3553-62. PubMed ID: 11429702
    [Abstract] [Full Text] [Related]

  • 15. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
    van Ravenswaaij-Arts CM, Losekoot M.
    Ned Tijdschr Geneeskd; 2001 Jun 02; 145(22):1056-9. PubMed ID: 11414167
    [Abstract] [Full Text] [Related]

  • 16. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.
    Camera G, Baldi M, Strisciuglio G, Concolino D, Mastroiacovo P, Baffico M.
    Am J Med Genet; 2001 Dec 15; 104(4):277-81. PubMed ID: 11754059
    [Abstract] [Full Text] [Related]

  • 17. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
    van Rhijn BW, van Tilborg AA, Lurkin I, Bonaventure J, de Vries A, Thiery JP, van der Kwast TH, Zwarthoff EC, Radvanyi F.
    Eur J Hum Genet; 2002 Dec 15; 10(12):819-24. PubMed ID: 12461689
    [Abstract] [Full Text] [Related]

  • 18. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
    Tavormina PL, Shiang R, Thompson LM, Zhu YZ, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ.
    Nat Genet; 1995 Mar 15; 9(3):321-8. PubMed ID: 7773297
    [Abstract] [Full Text] [Related]

  • 19. Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells.
    Nowroozi N, Raffioni S, Wang T, Apostol BL, Bradshaw RA, Thompson LM.
    Hum Mol Genet; 2005 Jun 01; 14(11):1529-38. PubMed ID: 15843401
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.